Navigation Links
Glaucoma Research Foundation Celebrates National Glaucoma Awareness Month
Date:12/29/2008

SAN FRANCISCO, Dec. 29 /PRNewswire/ -- In celebration of National Glaucoma Awareness Month, Glaucoma Research Foundation (GRF) will commemorate its 31st Anniversary with a benefit at the historic Palace Hotel in San Francisco, Jan. 28, 2009. The annual event serves as the showcase for recent advances in GRF-funded research.

Glaucoma is the leading cause of preventable blindness. With an aging population, millions worldwide risk blindness from glaucoma if nothing is done. "Early detection and treatment is the only way to prevent further vision loss," says Thomas M. Brunner, GRF president and CEO. "At GRF, we believe that a cure is attainable in the future and National Glaucoma Awareness Month helps us raise awareness for potential treatments and cures available to glaucoma patients today."

The Benefit begins at 5 p.m. with a scientific overview of recent research advances presented by the four principal investigators of GRF's Catalyst for a Cure (CFC) consortium. A reception follows at 6 p.m. and dinner commences at 7 p.m.

Individual Benefit tickets are $300, with tables available at $25,000, $15,000, $10,000 and $6,000. For information or to receive an invitation, please contact Craig Palmer, 415.986.3162 or cpalmer@glaucoma.org.

About the Glaucoma Research Foundation

Glaucoma is the leading cause of preventable blindness. Founded in 1978 in San Francisco, the Glaucoma Research Foundation is the oldest national foundation dedicated to preventing vision loss from glaucoma by investing in innovative research, education and support with the ultimate goal of finding a cure.

http://www.glaucoma.org


'/>"/>
SOURCE Glaucoma Research Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Glaucoma surgery in the blink of an eye
3. Glaucoma surgery in the blink of an eye
4. Chair of U.S. Preventive Services Task Force Pledges to Recommend Re-evaluation of Recent Glaucoma Findings
5. Looking at Glaucoma as a Systemic Disease
6. Cost of glaucoma medications may impact treatment
7. January is National Glaucoma Awareness Month
8. Upcoming meeting will explore new technologies for glaucoma clinical drug trials
9. Dr. Welsh Self-Test Diagnoses Glaucoma, the Leading Cause of Preventable- Blindness
10. Mayor Bloomberg Declares March 6, 2008 World Glaucoma Day in New York City
11. Glaucoma May Boost Cardiovascular Death Risk in Blacks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Shamangelic Healing, Sedona ... Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula for brain optimization and ... products to the store is just one more way Shamangelic Healing supports people’s ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... ... advocating optimistic healthcare awareness and author of best seller "LOVE, MEDICINE and MIRACLES") ... Radio Monday, May 2, 2016 and podcasted thereafter . Dr. Bernie Siegel, ...
(Date:4/29/2016)... Fla. (PRWEB) , ... April 29, 2016 , ... ... Hospital surgeon reveals that infants born with severe congenital diaphragmatic hernia have better ... is born with congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... patented products, announces the Gyrociser, an exercise invention which aids in proper muscle ... says Scott Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has ...
(Date:4/29/2016)... ... , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is ... treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients ... or both jaw bones. This surgery is performed to correct the alignment of the jaw. ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Calif. , April 28, 2016  Marking ... widely accessible breast and ovarian cancer risk test, ... panel analyzing 30 genes that highly impact the ... women. Available today, the Color Test analyzes hereditary ... prostate, stomach, and uterine cancers. The Color Test ...
(Date:4/28/2016)... 28, 2016 , Net Sales of $1.90 ... over the prior year period, and an increase of 1.2% ... Diluted EPS for the first quarter were $0.52 reported, a ... adjusted, an increase of 29.9% over the prior year period ... earnings guidance for 2016 Zimmer Biomet Holdings, Inc. ...
(Date:4/28/2016)... 28, 2016  ValGenesis, Inc., the market ... (VLMS) today announced that a prominent world ... of chronic kidney failure has selected ValGenesis ... corporate validation process. The global medical device ... to manage their validation processes electronically. Upon ...
Breaking Medicine Technology: